TickerFactsScreenerDevelopers

Emmaus Life Sciences, Inc. (EMMA) — Operating Income

Annual figures by fiscal year, from SEC filings.

2010: -$6.50M2011: -$5.29M2012: -$4.81M2013: -$4.20M2014: -$3.82M2015: -$2.65M2016: -$3.77M2017: -$7.10M2018: -$8.45M2019: -$4.51M2020: -$32.0K2021: -$6.13M2022: -$6.59M2023: $3.54M2024: -$1.89M2025: $231.0K$231.0K
2010Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$231.0K+112.2%
2024-$1.89M-153.5%
2023$3.54M+153.8%
2022-$6.59M-7.5%
2021-$6.13M-19050.0%
2020-$32.0K+99.3%
2019-$4.51M+46.6%
2018-$8.45M-19.0%
2017-$7.10M-88.6%
2016-$3.77M-42.2%
2015-$2.65M+30.6%
2014-$3.82M+9.1%
2013-$4.20M+12.6%
2012-$4.81M+9.2%
2011-$5.29M+18.7%
2010-$6.50M—